Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Spondylitis, Ankylosing 1Psoriasis 1Herpes Zoster 1Crohn Disease 1Arthritis, Rheumatoid 1Arthritis, Psoriatic 1Arthritis 1

Interventions

Nutrition Assessment 2Collagenases 2upadacitinib 1tocilizumab 1Vaccines 1Transcutaneous Electric Nerve Stimulation 1Saline Solution 1Resistance Training 1Omeprazole 1Naproxen 1Melphalan 1Lysine Acetyltransferase 5 1Injections, Intra-Articular 1Immune Checkpoint Inhibitors 1Herpes Zoster Vaccine 1Febuxostat 1Exercise Therapy 1Colchicine 1Cari-D-Tect 1Arthroplasty, Replacement, Shoulder 1Arthroplasty, Replacement, Elbow 1Allopurinol 1Adalimumab 1Abatacept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Arthritis × Herpes Zoster Vaccine × Clear all
NCT02538341 2021-11-23

Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)

University of Alabama at Birmingham

Phase 2 Completed
617 enrolled 17 charts

Arthritis, Arthritis, Rheumatoid, Crohn Disease, Psoriasis, Spondylitis, Ankylosing, Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡